Neurogenic hypothesis of antiobesity action: is it on the horizon? - Top-Institutions - MDSpire

Neurogenic hypothesis of antiobesity action: is it on the horizon?

  • By

  • David Petrik

  • November 25, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neuroendocrinology
    • Obesity Research
    • Pharmacology

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neuroscience
    • Endocrinology
    • Obesity Pharmacotherapy

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neuroendocrinology
    • Obesity Medicine
    • Translational Research

  • #4

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, TN

    Key Differentiators

    • Neuroscience
    • Endocrinology
    • Metabolic Disease

Original Source(s)

Neurogenic hypothesis of antiobesity action: is it on the horizon?

  • by David Petrik

  • November 25, 2025

Related Content

Birthweight, Childhood BMI: What Drives the Link?

Mendelian randomization analyses linked higher birthweight with greater mid-childhood height but the connection could reflect genetic factors related to skeletal growth.

The role of metabolic reprogramming in oocyte development: research progress and prospects

Comparison of the association and discriminatory ability of CVAI, LAP, CI, and AVI for type 2 diabetes in Chinese adults aged ≥ 50 years: a sex-specific analysis